Author

Lekshmi Maya

Institution: Intellia Therapeutics (United States)

Observed institution: Intellia Therapeutics (United States)

OpenAlex ID: A5114524918

Engineering antigen-driven co-stimulation and T helper cell activity into TCR-T cells with CD8-41BB fusion receptors enhances anti-tumor activity

2026 · Ivy Dutta, Justin Oh, et al. · bioRxiv (Cold Spring Harbor Laboratory)

388 Engineering co-stimulation into TCR-T cells via a CD8–41BB fusion receptor enhances efficacy and durability in preclinical models of heme and solid tumor malignancies

2024 · Aaron Prodeus, Ivy Dutta, et al. · Journal for ImmunoTherapy of Cancer

Works count: 2

Citation count:

H-index:

I10-index: